Based on our study, we observed that SMAD3 and STAT3 could be potential diagnostic biomarkers for RA as well as that in RA patients with DAS-28 > 5.1, SOCS1, and STAT3 mRNA levels were lower in Treg cells and higher in Th17 cells. This evidence concerns the gene SMAD3 and rheumatoid arthritis.